Start
Cancer
Technology
Products & Services
Pipeline
News
Publications
Partners & Customers
About

Start
Cancer
Technology
Products & Services
Pipeline
News
Publications
Partners & Customers
About

Vernadsky challenge

Home » Vernadsky challenge

Vernadsky challenge

Vernadsky challenge

By Per Setterberg

Posted June 16, 2021

In News

Vernadsky challenge2021-06-162021-09-13http://iscaffpharma.com/wp-content/uploads/2021/09/iscaff-logo-webb.pngIscaffpharmahttps://usercontent.one/wp/iscaffpharma.com/wp-content/uploads/2021/06/vernadsky.jpg200px200px

Recent Posts

Business Developer
May 1, 2024
Iscaffpharma’s first patent issued by the United States Patent and Trademark Office
January 26, 2024
SLAS honors Per Setterberg as fellow member
October 19, 2023

Recent Publications

17. Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells
December 16, 2024
16. Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development
April 26, 2024
15. Proteomics of cell-free breast cancer scaffolds identify clinically relevant imprinted proteins and cancer-progressing properties
April 4, 2024

Contact us

Org nr: 559120-9753
Iscaff Pharma AB
Erik Dahlbergsgatan 11A
411 26 Gothenburg
Sweden
contact@iscaffpharma.com

Copyright All Rights Reserved © 2023

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text.